EcoDrugPlus

Toll Like Receptor 7

Ensembl ID : ENSSFOG00015003184
Gene Symbol: TLR7
3 Cross references
197 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSSFOG00015030720
Gene Symbol: TAAR1
3 Cross references
150 Possible Orthologues:

Trace Amine Associated Receptor 1

Ensembl ID : ENSSFOG00015020328
Gene Symbol: TAAR1
3 Cross references
150 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1-Like

Ensembl ID : ENSSFOG00015000259
Gene Symbol: LOC108937556
3 Cross references
155 Possible Orthologues:

Transient Receptor Potential Cation Channel Subfamily A Member 1-Like

Ensembl ID : ENSSFOG00015013058
Gene Symbol: LOC108935409
3 Cross references
133 Possible Orthologues:

Transmembrane Emp24 Domain-Containing Protein 3-Like

Ensembl ID : ENSSFOG00015020007
Gene Symbol: LOC108941167
3 Cross references
205 Possible Orthologues:

Transthyretin (Prealbumin, Amyloidosis Type I)

Ensembl ID : ENSSFOG00015025678
Gene Symbol: TTR
1 Cross references
178 Possible Orthologues:

Tryptophan 5-Hydroxylase 1-Like

Ensembl ID : ENSSFOG00015009712
Gene Symbol: LOC108941264
3 Cross references
200 Possible Orthologues:

Tryptophan 5-Hydroxylase 1-Like

Ensembl ID : ENSSFOG00015022493
Gene Symbol: LOC108942210
3 Cross references
200 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSSFOG00015005821
Gene Symbol: TUBA4A
3 Cross references
167 Possible Orthologues:

Tubulin Alpha Chain-Like

Ensembl ID : ENSSFOG00015025297
Gene Symbol: LOC108920693
3 Cross references
195 Possible Orthologues:

Tubulin Alpha-1c Chain-Like

Ensembl ID : ENSSFOG00015025506
Gene Symbol: LOC108918534
2 Cross references
119 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).